Online Learning > Webinars > Addiction Tox Case Conference

Addiction Toxicology Case Conference


As of September 2020, ACMT's recurring "Addiction Toxicology Case Conference" takes place on the first Friday of the month!

September-January, the Addiction Toxicology Case Conference will be a joint webinar series hosted by the American College of Medical Toxicology (ACMT), American Society of Addiction Medicine (ASAM) and the Opioid Response Network (ORN).

The co-hosted series will continue to be an interactive discussion of addiction toxicology cases, and will feature ASAM members along with ACMT members, as well as guest experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology. Cases will predominantly focus on the addiction medicine specialty in the new world of COVID-19.

Next Webinar: Friday, November 6, 2020 @ 1:00 pm EDT (New York)

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this internet live course for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The American College of Medical Toxicology. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

ACMT/ASAM/ORN Addiction Toxicology Case Conferences


ACMT/ASAM Addiction Toxicology Case Conferences

For previous Addiction Toxicology Case Conferences, please visit our archive.





Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.